Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions

被引:51
|
作者
Jiang, Xing [1 ,2 ]
Ren, Li [1 ,3 ]
Tebon, Peyton [1 ]
Wang, Canran [1 ,4 ]
Zhou, Xingwu [1 ]
Qu, Moyuan [1 ,5 ,6 ]
Zhu, Jixiang [1 ,7 ]
Ling, Haonan [1 ,8 ]
Zhang, Shiming [1 ,9 ]
Xue, Yumeng [1 ,10 ]
Wu, Qingzhi [1 ,11 ]
Bandaru, Praveen [1 ]
Lee, Junmin [1 ,12 ]
Kim, Han-Jun [1 ,12 ]
Ahadian, Samad [1 ,12 ]
Ashammakhi, Nureddin [1 ]
Dokmeci, Mehmet R. [1 ,12 ]
Wu, Jinhui [13 ,14 ]
Gu, Zhen [1 ]
Sun, Wujin [1 ,12 ]
Khademhosseini, Ali [1 ,12 ]
机构
[1] Univ Calif Los Angeles, Calif Nanosyst Inst, Ctr Minimally Invas Therapeut, Dept Bioengn, Los Angeles, CA 90095 USA
[2] Nanjing Univ Chinese Med, Sch Nursing, Nanjing 210023, Peoples R China
[3] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Shaanxi, Peoples R China
[4] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200025, Peoples R China
[5] Zhejiang Univ, Sch Med, Sch Stomatol, Affiliated Hosp Stomatol, Hangzhou 310006, Zhejiang, Peoples R China
[6] Key Lab Oral Biomed Res Zhejiang Prov, Hangzhou 310006, Zhejiang, Peoples R China
[7] Guangzhou Med Univ, Sch Basic Med Sci, Dept Biomed Engn, Guangzhou 511436, Peoples R China
[8] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA
[9] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Peoples R China
[10] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710000, Peoples R China
[11] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China
[12] Terasaki Inst Biomed Innovat, Los Angeles, CA 90064 USA
[13] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Med, Nanjing 210093, Peoples R China
[14] Nanjing Univ, Sch Life Sci, Nanjing 210093, Peoples R China
基金
美国国家卫生研究院;
关键词
cancer immunotherapy; cancer-on-a-chip; drug screening; high-throughput observation chamber; immune checkpoint inhibitors;
D O I
10.1002/smll.202004282
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cancer immunotherapies, including immune checkpoint inhibitor (ICI)-based therapies, have revolutionized cancer treatment. However, patient response to ICIs is highly variable, necessitating the development of methods to quickly assess efficacy. In this study, an array of miniaturized bioreactors has been developed to model tumor-immune interactions. This immunotherapeutic high-throughput observation chamber (iHOC) is designed to test the effect of anti-PD-1 antibodies on cancer spheroid (MDA-MB-231, PD-L1+) and T cell (Jurkat) interactions. This system facilitates facile monitoring of T cell inhibition and reactivation using metrics such as tumor infiltration and interleukin-2 (IL-2) secretion. Status of the tumor-immune interactions can be easily captured within the iHOC by measuring IL-2 concentration using a micropillar array where sensitive, quantitative detection is allowed after antibody coating on the surface of array. The iHOC is a platform that can be used to model and monitor cancer-immune interactions in response to immunotherapy in a high-throughput manner.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
    Frankel, Arthur E.
    Deshmukh, Sachin
    Reddy, Amit
    Lightcap, John
    Hayes, Maureen
    McClellan, Steven
    Singh, Seema
    Rabideau, Brooks
    Glover, T. Grant
    Roberts, Bruce
    Koh, Andrew Y.
    INTEGRATIVE CANCER THERAPIES, 2019, 18
  • [42] How to use immune checkpoint inhibitor in ovarian cancer?
    Park, Junsik
    Lee, Jung-Yun
    Kim, Sunghoon
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (05)
  • [43] Radiotherapy plus immune checkpoint inhibitor in prostate cancer
    Li, Tianjie
    Qian, Xinye
    Liu, Jinyang
    Xue, Feng
    Luo, Jing
    Yao, Guanqun
    Yan, Jun
    Liu, Xiaodong
    Xiao, Bo
    Li, Jianxing
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Immune Checkpoint Inhibitor Associated Pneumonitis In Lung Cancer
    Juenger, K.
    Abdulhaq, H.
    Bilello, K.
    Upadhyay, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment
    Portillo-Lara, R.
    Annabi, N.
    LAB ON A CHIP, 2016, 16 (21) : 4063 - 4081
  • [46] Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity
    Suresh, Karthik
    D'Alessio, Franco
    CRITICAL CARE MEDICINE, 2019, 47 (09) : E788 - E788
  • [47] Mapping the functional interactions at the tumor-immune checkpoint interface
    Bozorgui, Behnaz
    Kong, Elisabeth K.
    Luna, Augustin
    Korkut, Anil
    CANCER RESEARCH, 2023, 83 (07)
  • [48] Mapping the functional interactions at the tumor-immune checkpoint interface
    Behnaz Bozorgui
    Elisabeth K. Kong
    Augustin Luna
    Anil Korkut
    Communications Biology, 6
  • [49] Mapping the functional interactions at the tumor-immune checkpoint interface
    Bozorgui, Behnaz
    Kong, Elisabeth K.
    Luna, Augustin
    Korkut, Anil
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [50] Development of a Bladder Cancer-on-a-Chip Model to Assess Bladder Cancer Cell Invasiveness
    Ewell, Desiree J.
    Vue, Nita
    Moinuddin, Sakib M.
    Sarkar, Tanoy
    Ahsan, Fakhrul
    Vinall, Ruth L.
    CANCERS, 2024, 16 (15)